Related references
Note: Only part of the references are listed.The Supplement Adulterant β-Methylphenethylamine Increases Blood Pressure by Acting at Peripheral Norepinephrine Transporters
Charles W. Schindler et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Detection and quantification of phenethylamines in sports dietary supplements by NMR approach
Jianping Zhao et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2018)
Comprehensive review of cardiovascular toxicity of drugs and related agents
Premysl Mladenka et al.
MEDICINAL RESEARCH REVIEWS (2018)
Boost Me: Prevalence and Reasons for the Use of Stimulant Containing Pre Workout Supplements Among Fitness Studio Visitors in Mainz (Germany)
Matthias Dreher et al.
FRONTIERS IN PSYCHOLOGY (2018)
Overview of regulation of dietary supplements in the USA and issues of adulteration with phenethylamines (PEAs)
Rahul S. Pawar et al.
DRUG TESTING AND ANALYSIS (2017)
N-Alkylated Analogs of 4-Methylamphetamine (4-MA) Differentially Affect Monoamine Transporters and Abuse Liability
Ernesto Solis et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Structure-Activity Relationships of Substituted Cathinones, with Transporter Binding, Uptake, and Release
Amy J. Eshleman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Cytochrome P450 2D6 and 3A4 enzyme inhibition by amine stimulants in dietary supplements
Yitong Liu et al.
DRUG TESTING AND ANALYSIS (2016)
Pharmacological mechanisms underlying the cardiovascular effects of the bath salt constituent 3,4-methylenedioxypyrovalerone (MDPV)
Charles W. Schindler et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Individual Differences in the Reinforcing and Subjective Effects of d-Amphetamine: Dimensions of Impulsivity
Arit Harvanko et al.
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2016)
Direct and indirect cardiovascular actions of cathinone and MDMA in the anaesthetized rat
Hadeel A. Alsufyani et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
LC-MS-MS Analysis of N,α-Diethylphenethylamine (N,α-ETH) and Its Positional Isomer N,β-Diethylphenethylamine (N,β-ETH) in Dietary Supplements
Mahmoud A. ElSohly et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2015)
Determination of designer doping agent-2-ethylamino-1-phenylbutane - in dietary supplements and excretion study following single oral supplement dose
Marzena Wojtowicz et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2015)
Reliable identification and quantification of three diethylphenethylamines in a Dendrobium-based dietary supplement
R. Wahlstrom et al.
ANALYTICAL METHODS (2014)
Fatal Caffeine Overdose and Other Risks from Dietary Supplements
E. Randy Eichner
CURRENT SPORTS MEDICINE REPORTS (2014)
A methamphetamine analog (N,α-diethyl-phenylethylamine) identified in a mainstream dietary supplement
Pieter A. Cohen et al.
DRUG TESTING AND ANALYSIS (2014)
Inhibition of monoamine oxidase (MAO) by α-ethylphenethylamine and N,α-diethylphenethylamine, two compounds related to dietary supplements
Michael F. Santillo
FOOD AND CHEMICAL TOXICOLOGY (2014)
LC-MS-MS Analysis of Dietary Supplements for N-ethyl-α-ethyl-phenethylamine (ETH), N, N-diethylphenethylamine and Phenethylamine
Mahmoud A. ElSohly et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2014)
Designer Phenethylamines Routinely Found in Human Urine: 2-Ethylamino-1-Phenylbutane and 2-Amino-1-Phenylbutane
Victor Uralets et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2014)
Identification of N-ethyl-alpha-ethylphenethylamine in crystalline powder seized for suspected drug trafficking: a research chemical or a new designer drug?
Jaesin Lee et al.
FORENSIC TOXICOLOGY (2013)
Powerful Cocaine-Like Actions of 3,4-Methylenedioxypyrovalerone (MDPV), a Principal Constituent of Psychoactive 'Bath Salts' Products
Michael H. Baumann et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Comparison of the behavioral and cardiovascular effects of mephedrone with other drugs of abuse in rats
Kurt J. Varner et al.
PSYCHOPHARMACOLOGY (2013)
Automated design of ligands to polypharmacological profiles
Jeremy Besnard et al.
NATURE (2012)
Evidence for the Involvement of Dopamine Transporters in Behavioral Stimulant Effects of Modafinil
Dorota Zolkowska et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Monoamine transporters and psychostimulant addiction
Leonard L. Howell et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Individual differences in drug abuse vulnerability: d-Amphetamine and sensation-seeking status
Thomas H. Kelly et al.
PSYCHOPHARMACOLOGY (2006)
Monoamine transporters and psychostimulant drugs
RB Rothman et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
(+)-Fenfluramine and its major metabolite, (+)-norfenfluramine, are potent substrates for norepinephrine transporters
RB Rothman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
CAL-B-catalyzed resolution of some pharmacologically interesting β-substituted isopropylamines
J González-Sabín et al.
TETRAHEDRON-ASYMMETRY (2002)